Metagenomics and metabolomics to evaluate the potential role of gut microbiota and blood metabolites in patients with cerebral infarction/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by KateRasheed on 2025-10-9

Curated date: 2025/10/09

Curator: Tosin

Revision editor(s): Tosin

Source: Figure 3A and 3B

Description: Cladogram and lefse results showing significant differential abundance between Healthy controls (H) and Patients with cerebral infarction (N)

Abundance in Group 1: decreased abundance in Cerebral infarction (N)

NCBI	Quality Control	Links
Achromobacter
Alcaligenaceae
Arthrobacter
Bacillota
Beijerinckiaceae
Butyricicoccaceae
Butyricicoccus
Campylobacterales
Campylobacterota
Cyanobacteriota
Cyanobium gracile PCC 6307
Cyanophyceae
Epsilonproteobacteria
Faecalibacterium
Flavonifractor
Fusicatenibacter
Haemophilus
Lachnospira
Lachnospira eligens
Lachnospiraceae bacterium NK4A136
Pasteurellaceae
Pasteurellales
Pediococcus
Prochlorococcaceae
Solobacterium
Subdoligranulum
Sulfuricurvum
Sulfurimonadaceae
Synechococcales
Tyzzerella
Veillonella
Veillonellaceae
Lachnospiraceae ND3007 groupLachnospiraceae ND3007 group
CyanobacteriaCyanobacteria

Revision editor(s): Tosin